LMR Partners’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

LMR Partners’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71K	Hold	1,624,856	–	–	﹤0.01%	1284
2025 Q4	$196K	Hold	1,624,856	–	–	﹤0.01%	1278
2025 Q3	$195K	Hold	1,624,856	–	–	﹤0.01%	1215
2025 Q2	$83.4K	Hold	1,624,856	–	–	﹤0.01%	1186
2025 Q1	$44K	Hold	1,624,856	–	–	﹤0.01%	1204
2024 Q4	$8.45K	Buy	+1,624,856	New	+$25.3K	﹤0.01%	1122
2024 Q3	–	Sell	-1,624,856	Closed	-$32.2K	–	1523
2024 Q2	$42.7K	Hold	1,624,856	–	–	﹤0.01%	940
2024 Q1	$325K	Hold	1,624,856	–	–	﹤0.01%	811
2023 Q4	$325K	Buy	1,624,856 +31,500	+2%	+$4.98K	﹤0.01%	692
2023 Q3	$146K	Buy	1,593,356 +24,792	+2%	+$2.02K	﹤0.01%	654
2023 Q2	$43.8K	Hold	1,568,564	–	–	﹤0.01%	675
2023 Q1	$1.06M	Buy	1,568,564 +99,100	+7%	+$12.2K	0.02%	564
2022 Q4	$2.42M	Buy	1,469,464 +262,954	+22%	+$85.8K	0.04%	470
2022 Q3	$5.59M	Buy	1,206,510 +10,124	+0.8%	+$7.05K	0.1%	244
2022 Q2	$6.05M	Buy	1,196,386 +172,395	+17%	+$159K	0.1%	240
2022 Q1	$7.3M	Buy	1,023,991 +858,573	+519%	+$780K	0.08%	243
2021 Q4	$1.61M	Buy	+165,418	New	+$205K	0.02%	541

Other funds holding STLNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

LMR Partners's STLNW Position: Q1 2026 in Review

LMR Partners held its Starling Oncology, Inc. Warrant (STLNW) position steady in Q1 2026 at 1,624,856 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

LMR Partners first reported a position in STLNW in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.3M in Q1 2022. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2026.

LMR Partners held 1,624,856 shares of Starling Oncology, Inc. Warrant worth $71K as of Q1 2026.
LMR Partners left its Starling Oncology, Inc. Warrant share count unchanged in Q1 2026.
Starling Oncology, Inc. Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1284 holding.
LMR Partners first reported a position in Starling Oncology, Inc. Warrant in Q4 2021 and has held it in 17 quarters since.
LMR Partners's Starling Oncology, Inc. Warrant position peaked at $7.3M in Q1 2022.
11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.